MedPath
NMPA Approval

Lenvatinib Mesilate Capsules

国药准字H20213600

July 20, 2021

Drug Information

甲磺酸仑伐替尼胶囊

胶囊剂

4mg(按C21H19ClN4O4计)

化学药品

July 20, 2021

Company Information

Applicant Company

江苏省连云港市郁州南路369号

Manufacturing Company

连云港市新浦区巨龙北路8号;江苏省连云港市郁州南路369号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸仑伐替尼胶囊 - NMPA 批准文号 | MedPath